FOXA2 Activates RND1 to Regulate Arachidonic Acid Metabolism Pathway and Suppress Cisplatin Resistance in Lung Squamous Cell Carcinoma.
Yafu ZhouHuiguo ChenJianhua YanQi YaoChunchu KongYou PengShengying XiaoJinsong YangPublished in: The clinical respiratory journal (2024)
Our study suggested that FOXA2 positively modulated the RND1-AA pathway, which repressed the resistance of LUSC cells to DDP.